TEAS Timing for Gastrectomy Recovery (TEAS-TIME Trial)

Official record

Identifier

NCT07714980

Recruiting locations

country

China

Interventions studied

Transcutaneous Electrical Acupoint StimulationSham Transcutaneous Electrical Acupoint Stimulation

Lead sponsor

The Affiliated Hospital of Qingdao University

Target enrolment

300 participants

Study type

INTERVENTIONAL

Phase

Not applicable

Status

Recruiting

First posted

Jul 20, 2026

Last updated on the registry

Oct 1, 2026

Age

18 Years – 80 Years

Sex

ALL

Study contact

The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.

Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

* Age 18 to 80 years, both sexes
* Endoscopically and radiographically confirmed resectable stage I-III gastric cancer (AJCC 8th edition)
* Scheduled to undergo laparoscopic radical gastrectomy
* Willing to sign the informed consent form and able to comply with all study procedures

Exclusion Criteria:

* American Society of Anesthesiologists (ASA) physical status ≥ IV
* Clinical stage IV gastric cancer
* Severe hepatic, renal, cardiovascular, or cerebrovascular diseases, or uncontrolled psychiatric disorders that may affect compliance or safety assessment
* Participation in another clinical trial or receipt of any form of acupoint stimulation (acupuncture, electroacupuncture, TEAS, etc.) within 1 month prior to enrollment
* Continuous use of opioids for more than 3 months prior to enrollment, with a daily dose ≥ 30 mg oral morphine equivalent
* Implanted cardiac pacemaker or other electronic stimulation device, or skin infection/lesion at the stimulation site
* Pregnancy or lactation
* Emergency surgery due to bleeding, perforation, obstruction, etc.
* Planned epidural anesthesia for the surgery

Indexed under

Gastric Cancer